TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs369150
log Bayes Factor = 15.0025
Chromosome 6   position 32,975,720  (GRCh37) Explore rs369150 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E10.9 Without complications
1.000 0.000 0.000
E10 Insulin-dependent diabetes mellitus
1.000 0.000 0.000
E10.3 With ophthalmic complications
1.000 0.000 0.000
E10.1 With ketoacidosis
0.973 0.027 0.000
E10.2 With renal complications
0.958 0.042 0.000
E10.4 With neurological complications
0.953 0.047 0.000
E10.6 With other specified complications
0.862 0.138 0.000
E10.8 With unspecified complications
0.859 0.141 0.000
E10.0 With coma
0.851 0.149 0.000
E10.5 With peripheral circulatory complications
0.838 0.162 0.000
E10.7 With multiple complications
0.827 0.173 0.000
E10-E14 Diabetes mellitus
0.734 0.266 0.000
E11 Non-insulin-dependent diabetes mellitus
0.629 0.371 0.000
E11.2 With renal complications
0.614 0.386 0.000
E14 Unspecified diabetes mellitus
0.578 0.422 0.000
E13 Other specified diabetes mellitus
0.564 0.436 0.000
E14.3 With ophthalmic complications
0.529 0.471 0.000
E12 Malnutrition-related diabetes mellitus
0.526 0.474 0.000
E11.5 With peripheral circulatory complications
0.499 0.501 0.000
E11.6 With other specified complications
0.496 0.504 0.000
E11.1 With ketoacidosis
0.495 0.505 0.000
E11.3 With ophthalmic complications
0.470 0.530 0.000
E14.6 With other specified complications
0.460 0.540 0.000
E11.7 With multiple complications
0.451 0.549 0.000
E13.3 With ophthalmic complications
0.445 0.555 0.000
E14.2 Withrenal complications
0.440 0.560 0.000
E14.8 With unspecified complications
0.435 0.564 0.000
E11.8 With unspecified complications
0.420 0.580 0.000
E14.7 With multiple complications
0.414 0.586 0.000
E14.5 With peripheral circulatory complications
0.414 0.586 0.000
E14.0 With coma
0.414 0.586 0.000
E13.8 With unspecified complications
0.404 0.596 0.000
E13.7 With multiple complications
0.404 0.596 0.000
E13.6 With other specified complications
0.404 0.596 0.000
E13.5 With peripheral circulatory complications
0.404 0.596 0.000
E13.4 With neurological complications
0.404 0.596 0.000
E13.2 With renal complications
0.404 0.596 0.000
E13.1 With ketoacidosis
0.404 0.596 0.000
E13.0 With coma
0.404 0.596 0.000
E13.9 Without complications
0.399 0.601 0.000
E14.1 With ketoacidosis
0.395 0.605 0.000
E12.9 Without complications
0.377 0.622 0.000
E12.8 With unspecified complications
0.377 0.622 0.000
E12.7 With multiple complications
0.377 0.622 0.000
E12.6 With other specified complications
0.377 0.622 0.000
E12.5 With peripheral circulatory complications
0.377 0.622 0.000
E12.4 With neurological complications
0.377 0.622 0.000
E12.3 With ophthalmic complications
0.377 0.622 0.000
E12.2 With renal complications
0.377 0.622 0.000
E12.1 With ketoacidosis
0.377 0.622 0.000
E12.0 With coma
0.377 0.622 0.000
E11.0 With coma
0.345 0.654 0.000
E14.4 With neurological complications
0.321 0.678 0.000
E11.4 With neurological complications
0.272 0.728 0.000
E14.9 Without complications
0.168 0.832 0.000
E16.2 Hypoglycaemia, unspecified
0.137 0.863 0.000
E16 Other disorders of pancreatic internal secretion
0.131 0.869 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.127 0.873 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.124 0.876 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.113 0.887 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.094 0.906 0.000
E16.8 Other specified disorders of pancreatic internal secretion
0.094 0.906 0.000
E16.4 Abnormal secretion of gastrin
0.094 0.906 0.000
E16.3 Increased secretion of glucagon
0.094 0.906 0.000
K90.0 Coeliac disease
0.000 0.907 0.093
E15 Nondiabetic hypoglycaemic coma
0.091 0.909 0.000
E40-E46 Malnutrition
0.085 0.915 0.000
E50-E64 Other nutritional deficiencies
0.070 0.929 0.000
E16.1 Other hypoglycaemia
0.066 0.933 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.061 0.939 0.000
E45 Retarded development following protein-energy malnutrition
0.061 0.939 0.000
E43 Unspecified severe protein-energy malnutrition
0.061 0.939 0.000
E42 Marasmic kwashiorkor
0.061 0.939 0.000
E41 Nutritional marasmus
0.061 0.939 0.000
E40 Kwashiorkor
0.061 0.939 0.000
E53 Deficiency of other B group vitamins
0.057 0.942 0.000
E46 Unspecified protein-energy malnutrition
0.057 0.943 0.000
E54 Ascorbic acid deficiency
0.053 0.947 0.000
E00-E07 Disorders of thyroid gland
0.052 0.948 0.000
E65-E68 Obesity and other hyperalimentation
0.051 0.948 0.000
E53.8 Deficiency of other specified B group vitamins
0.051 0.949 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.051 0.949 0.000
E63 Other nutritional deficiencies
0.051 0.949 0.000
E56 Other vitamin deficiencies
0.051 0.949 0.000
E50 Vitamin A deficiency
0.051 0.949 0.000
E60 Dietary zinc deficiency
0.051 0.949 0.000
E59 Dietary selenium deficiency
0.051 0.949 0.000
E58 Dietary calcium deficiency
0.051 0.949 0.000
E52 Niacin deficiency [pellagra]
0.051 0.949 0.000
E51 Thiamine deficiency
0.050 0.950 0.000
E44.1 Mild protein-energy malnutrition
0.044 0.956 0.000
E44.0 Moderate protein-energy malnutrition
0.044 0.956 0.000
E04 Other non-toxic goitre
0.043 0.957 0.000
E04.2 Non-toxic multinodular goitre
0.042 0.958 0.000
E53.1 Pyridoxine deficiency
0.041 0.958 0.000
E53.0 Riboflavin deficiency
0.041 0.958 0.000
E06 Thyroiditis
0.040 0.960 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.038 0.961 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.037 0.963 0.000
E00 Congenital iodine-deficiency syndrome
0.037 0.963 0.000
E67 Other hyperalimentation
0.037 0.963 0.000
E68 Sequelae of hyperalimentation
0.037 0.963 0.000
E07 Other disorders of thyroid
0.037 0.963 0.000
E50.9 Vitamin A deficiency, unspecified
0.036 0.963 0.000
E50.8 Other manifestations of vitamin A deficiency
0.036 0.963 0.000
E50.7 Other ocular manifestations of vitamin A deficiency
0.036 0.963 0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.036 0.963 0.000
E50.5 Vitamin A deficiency with night blindness
0.036 0.963 0.000
E50.4 Vitamin A deficiency with keratomalacia
0.036 0.963 0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.036 0.963 0.000
E50.2 Vitamin A deficiency with corneal xerosis
0.036 0.963 0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.036 0.963 0.000
E50.0 Vitamin A deficiency with conjunctival xerosis
0.036 0.963 0.000
E56.9 Vitamin deficiency, unspecified
0.036 0.963 0.000
E56.8 Deficiency of other vitamins
0.036 0.963 0.000
E56.1 Deficiency of vitamin K
0.036 0.963 0.000
E56.0 Deficiency of vitamin E
0.036 0.963 0.000
E63.9 Nutritional deficiency, unspecified
0.036 0.963 0.000
E63.8 Other specified nutritional deficiencies
0.036 0.963 0.000
E63.1 Imbalance of constituents of food intake
0.036 0.963 0.000
E63.0 Essential fatty acid [EFA] deficiency
0.036 0.963 0.000
E64.9 Sequelae of unspecified nutritional deficiency
0.036 0.963 0.000
E64.8 Sequelae of other nutritional deficiencies
0.036 0.963 0.000
E64.3 Sequelae of rickets
0.036 0.963 0.000
E64.2 Sequelae of vitamin C deficiency
0.036 0.963 0.000
E64.1 Sequelae of vitamin A deficiency
0.036 0.963 0.000
E64.0 Sequelae of protein-energy malnutrition
0.036 0.963 0.000
E61 Deficiency of other nutrient elements
0.036 0.964 0.000
E51.9 Thiamine deficiency, unspecified
0.036 0.964 0.000
E51.8 Other manifestations of thiamine deficiency
0.036 0.964 0.000
E51.1 Beriberi
0.036 0.964 0.000
E51.2 Wernicke's encephalopathy
0.035 0.965 0.000
E65 Localised adiposity
0.035 0.965 0.000
K90 Intestinal malabsorption
0.000 0.965 0.035
E06.9 Thyroiditis, unspecified
0.035 0.965 0.000
E11.9 Without complications
0.035 0.965 0.000
E53.9 Vitamin B deficiency, unspecified
0.034 0.966 0.000
E55 Vitamin D deficiency
0.033 0.966 0.000
E07.9 Disorder of thyroid, unspecified
0.032 0.968 0.000
E04.8 Other specified non-toxic goitre
0.031 0.969 0.000
E06.5 Other chronic thyroiditis
0.029 0.971 0.000
E06.4 Drug-induced thyroiditis
0.029 0.971 0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.029 0.971 0.000
E06.1 Subacute thyroiditis
0.029 0.971 0.000
E06.0 Acute thyroiditis
0.029 0.971 0.000
K90.8 Other intestinal malabsorption
0.000 0.972 0.028
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.027 0.973 0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.027 0.973 0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.027 0.973 0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.027 0.973 0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.027 0.973 0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.027 0.973 0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.027 0.973 0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.027 0.973 0.000
E67.8 Other specified hyperalimentation
0.027 0.973 0.000
E67.3 Hypervitaminosis D
0.027 0.973 0.000
E67.2 Megavitamin-B6 syndrome
0.027 0.973 0.000
E67.1 Hypercarotenaemia
0.027 0.973 0.000
E67.0 Hypervitaminosis A
0.027 0.973 0.000
E04.0 Non-toxic diffuse goitre
0.027 0.973 0.000
E07.1 Dyshormogenetic goitre
0.027 0.973 0.000
E07.0 Hypersecretion of calcitonin
0.027 0.973 0.000
E61.2 Magnesium deficiency
0.026 0.973 0.000
E61.9 Deficiency of nutrient element, unspecified
0.026 0.974 0.000
E61.8 Deficiency of other specified nutrient elements
0.026 0.974 0.000
E61.7 Deficiency of multiple nutrient elements
0.026 0.974 0.000
E61.6 Vanadium deficiency
0.026 0.974 0.000
E61.5 Molybdenum deficiency
0.026 0.974 0.000
E61.4 Chromium deficiency
0.026 0.974 0.000
E61.3 Manganese deficiency
0.026 0.974 0.000
E61.0 Copper deficiency
0.026 0.974 0.000
K90.3 Pancreatic steatorrhoea
0.000 0.975 0.025
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.975 0.025
K90.1 Tropical sprue
0.000 0.975 0.025
E06.3 Autoimmune thyroiditis
0.025 0.975 0.000
E04.9 Non-toxic goitre, unspecified
0.025 0.975 0.000
E55.0 Rickets, active
0.024 0.976 0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.977 0.023
E04.1 Non-toxic single thyroid nodule
0.023 0.977 0.000
K90.9 Intestinal malabsorption, unspecified
0.000 0.979 0.021
J33.0 Polyp of nasal cavity
0.018 0.982 0.000
E07.8 Other specified disorders of thyroid
0.017 0.982 0.000
E03 Other hypothyroidism
0.016 0.984 0.000
K60.3 Anal fistula
0.000 0.984 0.016
O70.0 First degree perineal laceration during delivery
0.016 0.984 0.000
E20-E35 Disorders of other endocrine glands
0.014 0.986 0.000
E26 Hyperaldosteronism
0.012 0.988 0.000
E03.5 Myxoedema coma
0.012 0.988 0.000
E03.4 Atrophy of thyroid (acquired)
0.012 0.988 0.000
E03.3 Postinfectious hypothyroidism
0.012 0.988 0.000
E03.1 Congenital hypothyroidism without goitre
0.012 0.988 0.000
E03.0 Congenital hypothyroidism with diffuse goitre
0.012 0.988 0.000
E03.8 Other specified hypothyroidism
0.012 0.988 0.000
E29 Testicular dysfunction
0.012 0.988 0.000
T42.4 Benzodiazepines
0.000 0.989 0.011
E25 Adrenogenital disorders
0.011 0.989 0.000
E61.1 Iron deficiency
0.010 0.989 0.001
E26.0 Primary hyperaldosteronism
0.011 0.989 0.000
E31 Polyglandular dysfunction
0.010 0.989 0.000
E26.9 Hyperaldosteronism, unspecified
0.010 0.990 0.000
E29.1 Testicular hypofunction
0.010 0.990 0.000
N08.3 Glomerular disorders in diabetes mellitus
0.010 0.990 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.010 0.990 0.000
E32 Diseases of thymus
0.010 0.990 0.000
E30 Disorders of puberty, not elsewhere classified
0.010 0.990 0.000
E20 Hypoparathyroidism
0.009 0.990 0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.009 0.991 0.000
E26.8 Other hyperaldosteronism
0.009 0.991 0.000
E26.1 Secondary hyperaldosteronism
0.009 0.991 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.009 0.991 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.991 0.009
E29.9 Testicular dysfunction, unspecified
0.008 0.991 0.000
E29.8 Other testicular dysfunction
0.008 0.991 0.000
E29.0 Testicular hyperfunction
0.008 0.991 0.000
E31.0 Autoimmune polyglandular failure
0.008 0.992 0.000
D41.0 Kidney
0.008 0.992 0.000
E25.9 Adrenogenital disorder, unspecified
0.008 0.992 0.000
E25.8 Other adrenogenital disorders
0.008 0.992 0.000
H66.9 Otitis media, unspecified
0.000 0.992 0.008
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.992 0.008
E34 Other endocrine disorders
0.008 0.992 0.000
F20.9 Schizophrenia, unspecified
0.008 0.992 0.000
E31.9 Polyglandular dysfunction, unspecified
0.008 0.992 0.000
E31.8 Other polyglandular dysfunction
0.008 0.992 0.000
E31.1 Polyglandular hyperfunction
0.008 0.992 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.992 0.008
E30.9 Disorder of puberty, unspecified
0.007 0.993 0.000
E30.8 Other disorders of puberty
0.007 0.993 0.000
E30.1 Precocious puberty
0.007 0.993 0.000
E30.0 Delayed puberty
0.007 0.993 0.000
E32.9 Disease of thymus, unspecified
0.007 0.993 0.000
E32.8 Other diseases of thymus
0.007 0.993 0.000
E32.1 Abscess of thymus
0.007 0.993 0.000
E32.0 Persistent hyperplasia of thymus
0.007 0.993 0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.007 0.993 0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.007 0.993 0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.007 0.993 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.993 0.007
E22 Hyperfunction of pituitary gland
0.007 0.993 0.000
K22.9 Disease of oesophagus, unspecified
0.007 0.993 0.000
E20.8 Other hypoparathyroidism
0.007 0.993 0.000
E20.1 Pseudohypoparathyroidism
0.007 0.993 0.000
E20.0 Idiopathic hypoparathyroidism
0.007 0.993 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.993 0.007
E55.9 Vitamin D deficiency, unspecified
0.006 0.993 0.000
T39.1 4-Aminophenol derivatives
0.000 0.993 0.007
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.007 0.993 0.000
T51.0 Ethanol
0.000 0.993 0.007
T42.0 Hydantoin derivatives
0.000 0.993 0.007
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.993 0.007
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.993 0.007
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.993 0.007
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.993 0.007
K12.2 Cellulitis and abscess of mouth
0.000 0.993 0.007
E20.9 Hypoparathyroidism, unspecified
0.006 0.993 0.000
E34.0 Carcinoid syndrome
0.006 0.993 0.000
F20 Schizophrenia
0.007 0.993 0.000
T36 Poisoning by systemic antibiotics
0.000 0.993 0.006
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.994 0.006
T42.2 Succinimides and oxazolidinediones
0.000 0.994 0.006
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.994 0.006
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.994 0.006
E21.4 Other specified disorders of parathyroid gland
0.006 0.994 0.000
E28 Ovarian dysfunction
0.006 0.994 0.000
S67.0 Crushing injury of thumb and other finger(s)
0.006 0.994 0.000
T40.4 Other synthetic narcotics
0.000 0.994 0.006
T42.1 Iminostilbenes
0.000 0.994 0.006
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.994 0.006
E34.5 Androgen resistance syndrome
0.006 0.994 0.000
E34.4 Constitutional tall stature
0.006 0.994 0.000
E34.3 Short stature, not elsewhere classified
0.006 0.994 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.006 0.994 0.000
E34.1 Other hypersecretion of intestinal hormones
0.006 0.994 0.000
E22.1 Hyperprolactinaemia
0.006 0.994 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.994 0.006
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.994 0.006
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.994 0.006
E24 Cushing's syndrome
0.005 0.994 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.994 0.006
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.006 0.994 0.000
F20.0 Paranoid schizophrenia
0.006 0.994 0.000
E34.8 Other specified endocrine disorders
0.005 0.994 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.994 0.006
T42.3 Barbiturates
0.000 0.994 0.006
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.994 0.006
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.994 0.006
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.994 0.006
T36.0 Penicillins
0.000 0.994 0.006
E66 Obesity
0.005 0.994 0.000
D37.7 Other digestive organs
0.006 0.994 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.994 0.005
T50.7 Analeptics and opioid receptor antagonists
0.000 0.994 0.005
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.994 0.005
T50.5 Appetite depressants
0.000 0.994 0.005
T50.4 Drugs affecting uric acid metabolism
0.000 0.994 0.005
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.994 0.005
T50.1 Loop [high-ceiling] diuretics
0.000 0.994 0.005
T50.0 Mineralocorticoids and their antagonists
0.000 0.994 0.005
F20.5 Residual schizophrenia
0.005 0.994 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.005 0.994 0.000
E22.8 Other hyperfunction of pituitary gland
0.005 0.994 0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
0.005 0.994 0.000
T40.6 Other and unspecified narcotics
0.000 0.995 0.005
E23 Hypofunction and other disorders of pituitary gland
0.005 0.995 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.995 0.005
T46.1 Calcium-channel blockers
0.000 0.995 0.005
T39.4 Antirheumatics, not elsewhere classified
0.000 0.995 0.005
T39.2 Pyrazolone derivatives
0.000 0.995 0.005
E21.2 Other hyperparathyroidism
0.005 0.995 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.995 0.005
K01.1 Impacted teeth
0.000 0.995 0.005
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.995 0.005
T40.8 Lysergide [LSD]
0.000 0.995 0.005
T40.7 Cannabis (derivatives)
0.000 0.995 0.005
T40.3 Methadone
0.000 0.995 0.005
T40.1 Heroin
0.000 0.995 0.005
T40.0 Opium
0.000 0.995 0.005
D39.1 Ovary
0.005 0.995 0.000
T38.9 Other and unspecified hormone antagonists
0.000 0.995 0.005
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.995 0.005
T38.7 Androgens and anabolic congeners
0.000 0.995 0.005
T38.5 Other oestrogens and progestogens
0.000 0.995 0.005
T38.4 Oral contraceptives
0.000 0.995 0.005
T38.2 Antithyroid drugs
0.000 0.995 0.005
T38.0 Glucocorticoids and synthetic analogues
0.000 0.995 0.005
T40.5 Cocaine
0.000 0.995 0.005
M54.39 Sciatica (Site unspecified)
0.000 0.995 0.005
F20.8 Other schizophrenia
0.005 0.995 0.000
F20.6 Simple schizophrenia
0.005 0.995 0.000
F20.4 Postschizophrenic depression
0.005 0.995 0.000
F20.3 Undifferentiated schizophrenia
0.005 0.995 0.000
F20.2 Catatonic schizophrenia
0.005 0.995 0.000
F20.1 Hebephrenic schizophrenia
0.005 0.995 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.995 0.005
T36.8 Other systemic antibiotics
0.000 0.995 0.005
T36.7 Antifungal antibiotics, systemically used
0.000 0.995 0.005
T36.6 Rifamycins
0.000 0.995 0.005
T36.5 Aminoglycosides
0.000 0.995 0.005
T36.4 Tetracyclines
0.000 0.995 0.005
T36.3 Macrolides
0.000 0.995 0.005
T36.2 Chloramphenicol group
0.000 0.995 0.005
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.995 0.005
E21.5 Disorder of parathyroid gland, unspecified
0.005 0.995 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.995 0.005
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.995 0.005
T47.7 Emetics
0.000 0.995 0.005
T47.6 Antidiarrhoeal drugs
0.000 0.995 0.005
T47.5 Digestants
0.000 0.995 0.005
T47.4 Other laxatives
0.000 0.995 0.005
T47.3 Saline and osmotic laxatives
0.000 0.995 0.005
T47.2 Stimulant laxatives
0.000 0.995 0.005
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.995 0.005
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.995 0.005
T46.7 Peripheral vasodilators
0.000 0.995 0.005
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.995 0.005
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.995 0.005
D41.2 Ureter
0.005 0.995 0.000
E28.9 Ovarian dysfunction, unspecified
0.004 0.995 0.000
E28.8 Other ovarian dysfunction
0.004 0.995 0.000
E28.1 Androgen excess
0.004 0.995 0.000
E28.0 Oestrogen excess
0.004 0.995 0.000
H17.9 Corneal scar and opacity, unspecified
0.005 0.995 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.995 0.004
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.995 0.004
T40.2 Other opioids
0.000 0.995 0.005
T50.8 Diagnostic agents
0.000 0.995 0.004
Z50.0 Cardiac rehabilitation
0.000 0.995 0.005
E22.0 Acromegaly and pituitary gigantism
0.004 0.995 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.002 0.995 0.003
E24.8 Other Cushing's syndrome
0.004 0.996 0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.004 0.996 0.000
E24.3 Ectopic ACTH syndrome
0.004 0.996 0.000
E24.1 Nelson's syndrome
0.004 0.996 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.996 0.004
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.004 0.996 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.996 0.004
T37.5 Antiviral drugs
0.000 0.996 0.004
T37.4 Anthelminthics
0.000 0.996 0.004
T37.3 Other antiprotozoal drugs
0.000 0.996 0.004
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.996 0.004
T37.1 Antimycobacterial drugs
0.000 0.996 0.004
T37.0 Sulphonamides
0.000 0.996 0.004
D37.1 Stomach
0.004 0.996 0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs
0.004 0.996 0.000
T41.5 Therapeutic gases
0.000 0.996 0.004
T41.4 Anaesthetic, unspecified
0.000 0.996 0.004
T41.3 Local anaesthetics
0.000 0.996 0.004
T41.2 Other and unspecified general anaesthetics
0.000 0.996 0.004
T41.1 Intravenous anaesthetics
0.000 0.996 0.004
T41.0 Inhaled anaesthetics
0.000 0.996 0.004
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.996 0.004
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.996 0.004
T48.5 Anti-common-cold drugs
0.000 0.996 0.004
T48.4 Expectorants
0.000 0.996 0.004
T48.3 Antitussives
0.000 0.996 0.004
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.996 0.004
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.996 0.004
T48.0 Oxytocic drugs
0.000 0.996 0.004
T49.9 Topical agent, unspecified
0.000 0.996 0.004
T49.8 Other topical agents
0.000 0.996 0.004
T49.7 Dental drugs, topically applied
0.000 0.996 0.004
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.996 0.004
T49.5 Ophthalmological drugs and preparations
0.000 0.996 0.004
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.996 0.004
T49.3 Emollients, demulcents and protectants
0.000 0.996 0.004
T49.2 Local astringents and local detergents
0.000 0.996 0.004
T49.1 Antipruritics
0.000 0.996 0.004
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.996 0.004
E27 Other disorders of adrenal gland
0.004 0.996 0.000
E66.1 Drug-induced obesity
0.004 0.996 0.000
T47.0 Histamine H(2)-receptor antagonists
0.000 0.996 0.004
E05 Thyrotoxicosis [hyperthyroidism]
0.004 0.996 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.996 0.004
D37.6 Liver, gallbladder and bile ducts
0.004 0.996 0.000
I49.4 Other and unspecified premature depolarisation
0.000 0.996 0.004
E28.3 Primary ovarian failure
0.004 0.996 0.000
D41.9 Urinary organ, unspecified
0.004 0.996 0.000
D41.7 Other urinary organs
0.004 0.996 0.000
D41.3 Urethra
0.004 0.996 0.000
D41.1 Renal pelvis
0.004 0.996 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.004 0.996 0.000
E23.1 Drug-induced hypopituitarism
0.004 0.996 0.000
M54.3 Sciatica
0.000 0.996 0.004
T38.1 Thyroid hormones and substitutes
0.000 0.996 0.004
E66.0 Obesity due to excess calories
0.004 0.996 0.000
J33 Nasal polyp
0.004 0.996 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.004 0.996 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.996 0.004
M54.36 Sciatica (Lumbar region)
0.000 0.996 0.004
E23.7 Disorder of pituitary gland, unspecified
0.004 0.996 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.996 0.004
S92.30 Fracture of metatarsal bone (closed)
0.000 0.996 0.004
E24.0 Pituitary-dependent Cushing's disease
0.003 0.996 0.001
D37.5 Rectum
0.004 0.996 0.000
M54.38 Sciatica (Sacral and sacrococcygeal region)
0.000 0.996 0.004
N05.9 Unspecified
0.000 0.996 0.004
E23.2 Diabetes insipidus
0.004 0.996 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.004 0.996 0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.004 0.996 0.000
D39.7 Other female genital organs
0.004 0.996 0.000
I49.5 Sick sinus syndrome
0.000 0.996 0.004
D37.3 Appendix
0.004 0.996 0.000
E24.2 Drug-induced Cushing's syndrome
0.003 0.996 0.001
E23.6 Other disorders of pituitary gland
0.003 0.996 0.000
K65.9 Peritonitis, unspecified
0.000 0.996 0.004
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.004 0.996 0.000
E27.2 Addisonian crisis
0.003 0.996 0.000
M54.37 Sciatica (Lumbosacral region)
0.000 0.996 0.003
D44.1 Adrenal gland
0.003 0.996 0.000
E34.9 Endocrine disorder, unspecified
0.002 0.996 0.001
J32.0 Chronic maxillary sinusitis
0.004 0.996 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.001 0.996 0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.001 0.996 0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.001 0.996 0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.001 0.996 0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.001 0.996 0.002
T44.1 Other parasympathomimetics [cholinergics]
0.001 0.996 0.002
T44.0 Anticholinesterase agents
0.001 0.996 0.002
D39.9 Female genital organ, unspecified
0.003 0.997 0.000
D39.2 Placenta
0.003 0.997 0.000
C67.5 Bladder neck
0.000 0.997 0.003
N08 Glomerular disorders in diseases classified elsewhere
0.003 0.997 0.000
E27.3 Drug-induced adrenocortical insufficiency
0.003 0.997 0.000
E27.5 Adrenomedullary hyperfunction
0.003 0.997 0.000
E27.0 Other adrenocortical overactivity
0.003 0.997 0.000
D39.0 Uterus
0.003 0.997 0.000
D44.4 Craniopharyngeal duct
0.003 0.997 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.001 0.997 0.002
F25 Schizoaffective disorders
0.003 0.997 0.000
E05.5 Thyroid crisis or storm
0.003 0.997 0.000
E05.4 Thyrotoxicosis factitia
0.003 0.997 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.003 0.997 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.003 0.997 0.000
H36.0 Diabetic retinopathy
0.003 0.997 0.000
E66.2 Extreme obesity with alveolar hypoventilation
0.003 0.997 0.000
T39.0 Salicylates
0.000 0.997 0.003
Z45.2 Adjustment and management of vascular access device
0.003 0.997 0.000
C71.1 Frontal lobe
0.000 0.997 0.003
T45.0 Antiallergic and antiemetic drugs
0.000 0.997 0.003
M54.35 Sciatica (Thoracolumbar region)
0.000 0.997 0.003
M54.34 Sciatica-Thoracic
0.000 0.997 0.003
M54.33 Sciatica-Cervicothoracic
0.000 0.997 0.003
M54.32 Sciatica-Cervical
0.000 0.997 0.003
M54.31 Sciatica-Occipit-atl-axl
0.000 0.997 0.003
M54.30 Sciatica (Multiple sites in spine)
0.000 0.997 0.003
D44.6 Carotid body
0.003 0.997 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.997 0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.002 0.997 0.002
T51 Toxic effect of alcohol
0.000 0.997 0.003
I08.0 Disorders of both mitral and aortic valves
0.000 0.997 0.003
E24.9 Cushing's syndrome, unspecified
0.003 0.997 0.001
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.997 0.003
T45.8 Other primarily systemic and haematological agents
0.000 0.997 0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.997 0.003
T45.6 Fibrinolysis-affecting drugs
0.000 0.997 0.003
T45.4 Iron and its compounds
0.000 0.997 0.003
T45.3 Enzymes, not elsewhere classified
0.000 0.997 0.003
D44.0 Thyroid gland
0.003 0.997 0.000
T24.3 Burn of third degree of hip and lower limb, except ankle and foot
0.003 0.997 0.000
F25.0 Schizoaffective disorder, manic type
0.003 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.